ADVANCED CELL DIAGNOSTICS, INC.

Advanced Cell Diagnostics, Inc. specializes in the development and manufacturing of highly specific in situ hybridization reagents and diagnostic kits for molecular pathology research, with a primary focus on RNAscope® technology. The company designs and produces proprietary nucleic acid probes and detection systems that enable sensitive, single-molecule visualization of RNA targets in formalin-fixed, paraffin-embedded tissues, supporting spatial transcriptomics and biomarker validation in complex biological samples. Their technical expertise lies in probe design, oligonucleotide synthesis, fluorescence labeling, and assay optimization for high-specificity, low-background detection in diagnostic and preclinical research environments. Key differentiators include proprietary signal amplification chemistry, multiplexed probe capabilities, and custom probe development for non-standard targets, making their solutions indispensable for labs conducting precision oncology, virology, and neurobiology research. The contractor maintains a consistent and dominant relationship with the Department of Health and Human Services, supplying critical reagents for infectious disease, malaria, and neurology research programs. Work performed under HHS contracts centers on providing validated diagnostic reagents for use in federally funded laboratories, often supporting public health surveillance and translational science initiatives. There is no evidence of engagement with other federal agencies beyond HHS. The contractor’s primary industry focus is in research and development in biotechnology and in-vitro diagnostic substance manufacturing, where they serve as a niche supplier of molecular detection tools for academic, government, and pharmaceutical research. Their market positioning is defined by proprietary probe-based technologies that enable high-resolution spatial gene expression analysis, filling a critical gap in tissue-based molecular diagnostics. Advanced Cell Diagnostics, Inc. is a small business headquartered in Newark, California, with no active government certifications. The company operates as a specialized life sciences vendor, leveraging its technical innovation to serve federal research missions without reliance on formal small business programs.